Syndax Pharmaceuticals, Inc. (SNDX)
20.76
+0.54
(+2.64%)
USD |
NASDAQ |
Dec 19, 16:00
20.76
0.00 (0.00%)
After-Hours: 18:25
Syndax Pharmaceuticals Shareholders Equity (Annual): 288.12M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Arcutis Biotherapeutics, Inc. | 157.54M |
| ACADIA Pharmaceuticals, Inc. | 732.79M |
| Verastem, Inc. | -28.89M |
| Puma Biotechnology, Inc. | 92.12M |
| Krystal Biotech, Inc. | 946.38M |